By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Shire Pharmaceuticals Group plc 

Hampshire International Business Park
Basingstoke  Hampshire  RG24 8EP  United Kingdom
Phone: 44-1256-894-000 Fax: 44-1256-894-708



Company News
Shire (SHPG) To Attain Enhanced CINRYZE Manufacturing Flexibility And Capacity 8/25/2015 8:36:35 AM
Shire (SHPG) and Baxalta Maneuver To Sweeten Bid Or Shut It Down 8/14/2015 6:02:39 AM
Shire (SHPG) Launches 2015 Excellence In ADHD Patient Group Awards 8/10/2015 9:19:48 AM
What Shire (SHPG)-Baxalta Would Look Like if the $30 Billion Merger Goes Through 8/5/2015 6:07:17 AM
Shire (SHPG) Goes Live on Rebuffed $30 Billion Merger with Baxalta to Pressure Stockholders, Board and Execs 8/4/2015 6:00:08 AM
Spree Continues as Shire (SHPG) Snaps Up New York Eye Drop Developer for $300 Million 8/3/2015 5:56:55 AM
Shire (SHPGY) Receives CHMP Positive Opinion In Europe For INTUNIV (guanfacine hydrochloride extended release) As A Non-Stimulant ADHD Treatment For Children And Adolescents 7/23/2015 2:00:28 PM
Shire (SHPGY) Announces Second Quarter Earnings And Increases Full Year Non GAAP Diluted EPS Guidance To Mid-To-High Single Digit Growth 7/23/2015 12:18:11 PM
Shire (SHPGY): Life One Year After a $54 Billion Takeover Collapse by AbbVie (ABBV) and Its Push Into Biotech 7/14/2015 6:43:02 AM
Shire (SHPGY) Launches Spotlight On Gaucher Film Contest And Calls For Video Entries Sharing Experiences Of Living With Gaucher Disease 7/1/2015 3:00:05 PM